M. Tamm (Basel, Switzerland), M. Van Der Eerden (Rotterdam, Netherlands)
Antioxidant defence at the beginning of community-acquired pneumonia with lung infiltrative affection of different duration
T. Zhavoronok, E. Stepovaya, N. Ryazanceva, F. Tetenev, T. Ageeva, S. Mishustin (Tomsk, Russian Federation)
|  |
Effect on duration of hospitalization by introducing a clinical pathway for pneumonia in a super-aging society
A. Nakagawa, T. Ikeue, K. Furuta, K. Morita, T. Tajiri, K. Maniwa, S. Watanabe, T. Sugita, S. Horikawa, H. Nishiyama (Wakayama, Japan)
|  |
Steroids are not associated with an improvement in clinical outcomes in hospitalized patients with community-acquired pneumonia (CAP)
P. Castellotti, V. Betti, V. Giunta, S. Aliberti, M. Pappalettera, P. Tarsia, P. Peyrani, J. A. Ramirez, F. Blasi (Milan, Italy; Louisville, United States Of America)
| |
Does the management and outcome of community-acquired pneumonia differ depending on the route of admission to hospital?
T. Bewick, W. S. Lim (Nottingham, United Kingdom)
| |
Hospital-acquired pneumonia in patients receiving immunosuppressive therapy
E. Cakir Edis, O. N. Hatipoglu, I. Yilmam, A. Eker, O. Tansel, N. Sut, E. Tekgunduz, M. Demir (Edirne, Turkey)
| |
Adherence to the American College of Chest Physicians‘ guidelines on the indication of pleural drainage in parapneumonic effusion
C. Lucena, J. Sellarés, C. Cilloniz, E. Polverino, J. A. Riesco, M. Ortega, M. A. Marcos, J. Mensa, A. Torres (Barcelona, Spain)
| |
Resolution characteristics of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia
P. Myrianthefs, K. Ioannides, G. Baltopoulos (Athens, Greece)
| |
Study on mechanism of resistance in Acinetobacter baumannii to quinolones
M. Huang, Y. Wang, W. Wang (Nanjing, China)
| |
Change of antibiotics resistance pattern of microorganism cultured in tracheal aspirates in mechanical ventilator patients after antibiotics restriction policy
Y. Hwang, H. Kim, C. Lee (Jinju, Republic Of Korea)
| |
Importance of setting the correct antibiotherapy in intensive care units
A. Yalcin, E. Sen, S. Erol, A. Ciledag, Z. P. Onen, B. Gülbay, A. Kaya (Cebeci, Turkey)
| |
Does overprescribing antibiotics (abx) put patients (pts) at risk? A two part retrospective study
A. Collins, E. Brohan, V. Price, A. De Ramon (Warrington, United Kingdom)
| |
Hospital doctors‘ knowledge of current antibiotic (abx) guidelines
A. Collins, E. Brohan, V. Price, A. De Ramon (Warrington, United Kingdom)
| |
Resections lung of pulmonary hydatid cysts
C. Mitrofan, D. Barzu, C. E. Mitrofan, L. Farmatu (Iasi, Romania)
| |
Empyema thoracis: therapeutic management and outcome
A. Zouaoui, S. Sanai, J. Cherif, N. Rojbi, N. Mehiri, Z. Souissi, H. Smadhi, S. Mahmoud, M. Osman, I. Saada, B. Louzir, J. Daghfous, M. Beji (Tunis, Tunisia)
| |
Pleuropulmonary manifestations disclosing hepatic amebiasis
F. Rivière, H. Le Floch, A. Bonnichon, P. Saint Blancard, P. L‘Her, A. Mairovitz, C. Marotel, F. Vaylet, J. Margery (Clamart, France)
| |
Dispersion of exhaled air during oxygen delivery via a venturi mask
D. Hui, B. Chow, S. Hall, L. Chu, S. Ng, T. Gin, M. Chan (Shatin, Hong Kong; Sydney, Australia)
| |
Exhaled air dispersion distances during oxygen delivery via a non-rebreathing mask
D. Hui, B. Chow, S. Hall, L. Chu, S. Ng, T. Gin, M. Chan (China; , Australia)
| |
Tuberculosis pneumonia: a study of 59 cases
J. B. Fochesatto, M. Pereira, A. L. Moreira, J. Moreira (Porto Alegre, Brazil)
| |
Pulmonary infection with nontuberculous mycobacteria: management and follow up of 5 infected patients
A. Simsek, Z. M. Guler, R. Ofluoglu, E. Unsal, N. Capan (Ankara, Turkey)
| |
The emerging problem of treating pulmonary M. avium complex (MAC) disease – microbial substitution of MAC to M. abscessus, Scedosporium and Nocardia after multi-drug chemotherapy in pulmonary MAC disease
M. Matsuyama, A. Moriya, K. Shimizu, N. Kokuho, Y. Miura, S. Otsuka, T. Kiwamoto, K. Hayashihara, T. Saito (Nakagun Tokai-mura, Japan)
| |